Callan JMB Inc. (NASDAQ:CJMB) Short Interest Up 273.6% in June

Callan JMB Inc. (NASDAQ:CJMB) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 329,344 shares, an increase of 273.6% from the May 31st total of 88,152 shares. Currently, 22.3% of the shares of the company are short sold. Based on an average daily volume of 557,370 shares, the short-interest ratio is presently 0.6 days.

Callan JMB Stock Up 3.8%

Shares of CJMB traded up $0.03 during trading hours on Monday, hitting $0.79. 4,833 shares of the company were exchanged, compared to its average volume of 1,981,080. Callan JMB has a fifty-two week low of $0.65 and a fifty-two week high of $5.88. The company has a market cap of $4.45 million, a price-to-earnings ratio of -0.38 and a beta of -0.06. The firm’s fifty day moving average is $0.89 and its 200 day moving average is $1.41.

Callan JMB (NASDAQ:CJMB) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.59) EPS for the quarter. Callan JMB had a negative net margin of 184.70% and a negative return on equity of 285.36%. The company had revenue of $1.11 million during the quarter.

Hedge Funds Weigh In On Callan JMB

A hedge fund recently raised its position in Callan JMB stock. Creative Planning increased its position in shares of Callan JMB Inc. (NASDAQ:CJMB) by 41.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,008 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Creative Planning owned about 3.79% of Callan JMB worth $830,000 as of its most recent filing with the Securities and Exchange Commission.

Wall Street Analysts Forecast Growth

CJMB has been the topic of a number of research reports. Wall Street Zen raised Callan JMB to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Callan JMB in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Callan JMB Company Profile

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.